ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Screening"

  • 2015 American Transplant Congress

    Risk Factors Influencing Mammography Screening During Kidney Transplant Evaluation

    J. Stoecker, D. Cote, J. Augustine, N. Sarabu, J. Schulak, E. Sanchez, V. Humphreville, J. Ammori, K. Woodside.

    Transplant Institute, University Hospitals & Case Western Reserve University, Cleveland, OH.

    INTRO:Transplant centers typically require mammography (MMG) for women ≥ 40 as part of the evaluation process. The American Cancer Society recommends annual mammograms for the…
  • 2015 American Transplant Congress

    The Value of Surveillance Testing for De Novo Donor Specific Antibodies Following Renal Transplantation

    O. Pankewycz,1 M. Laftavi,2 M. Said,2 K. Chapin,2 L. Feng.2

    1Medicine, SUNY at Buffalo/ECMC, Buffalo, NY; 2Surgery, SUNY at Buffalo/ECMC, Buffalo, NY.

    The development of de novo donor specific antibodies (dnDSA) usually leads to a reduction in renal graft survival. The deleterious influence of dnDSA is most…
  • 2015 American Transplant Congress

    Screening Recipients of Increased Risk Donor Organs: A Multicenter Study

    N. Theodoropoulos,1 K. Brizendine,2 M. Ison.3

    1Infectious Diseases, The Ohio State University, Columbus, OH; 2Infectious Disease, Cleveland Clinic, Cleveland, OH; 3Infectious Diseases/Organ Transplantation, Northwestern University, Chicago, IL.

    Purpose: Policy mandates post-transplant (tx) evaluation of recipients of increased risk donor organs (ROIRDO). PHS guidelines recommend that screening include HIV & hepatitis C virus…
  • 2015 American Transplant Congress

    Current Dialysis, Previous Kidney Transplant, and Autoimmune Disease Increase Risk for Abnormal Pap Smear in Women Undergoing Kidney Transplant Evaluation

    K. Chaung,1 Y. Zheng,1 A. Martella,2 J. Stoecker,1 D. Cote,1 J. Augustine,2 E. Sanchez,2 V. Humphreville,2 J. Ammori,2 K. Woodside.2

    1Case Western Reserve University School of Medicine, Cleveland, OH; 2University Hospitals, Cleveland, OH.

    The USPSTF recommends Pap smears every three years for women 21-65, with optional combination Pap smear and HPV testing every five years for women 30-65.…
  • 2015 American Transplant Congress

    Detecting Bowel Cancer in Pre-Dialysis, Dialysis Patients and Kidney Transplant Recipients – The DETECT Study

    G. Wong, J. Chapman, J. Craig.

    University of Sydney, Sydney, NSW, Australia.

    Background: Colorectal cancer (CRC) is the third most common solid organ cancer in people living with kidney disease, and has a very poor prognosis, with…
  • 2015 American Transplant Congress

    The Effects of Dialysis Vintage and Hypertensive Renal Failure on Colonoscopy Findings During Kidney Transplant Evaluation

    Y. Zheng,1 K. Chaung,1 P. Park,1 J. Augustine,2 N. Sarabu,2 J. Schulak,2 E. Sanchez,2 V. Humphreville,2 J. Ammori,2 K. Woodside.2

    1School of Medicine, Case Western Reserve University, Cleveland, OH; 2Department of Surgery, University Hospitals Case Medical Center, Cleveland, OH.

    Colonoscopy as a screening modality starting at age 50 has recently undergone scrutiny due to concerns over the risks and benefits. We sought to identify…
  • 2015 American Transplant Congress

    Predictive Value of Cardiovascular Risk Assessment Tools in Kidney Transplantation

    C. Dunn, A. Holtzman, M. Hung, S. Greenstein.

    Surgery, Albert Einstein College of Medicine, Bronx, NY.

    Cardiovascular disease is a major cause of morbidity and mortality following kidney transplantation. Many cardiovascular risk screening tools have been developed, but they have never…
  • 2015 American Transplant Congress

    Dermatology Is an Essential Part of Transplant Care: Report of a Two-Year Experience from a Transplant Dermatology Center

    E. Pritchett,1 B. Miller,1 A. Colasacco,1 G. Malat,2 A. Doyle,2 S. Guy,3 C. Cusack,1 C. Chung,1 M. Abdelmalek.1

    1Department of Dermatology, Drexel University College of Medicine, Philadelphia; 2Departent of Medicine, Drexel University College of Medicine, Philadelphia; 3Department of Surgery, Drexel University College of Medicine, Philadelphia.

    Background: It is well-documented that patients who have undergone organ transplantation have a higher incidence of new skin cancers and that this risk is magnified…
  • 2015 American Transplant Congress

    Negative Exercise Myocardial Perfusion Scintigraphy Discards Silent Coronary Artery Disease in High Cardiovascular Risk Patients Awaiting for Kidney Transplantation

    E. Melilli,1 V. Navarro,2 O. Bestard,1 A. Gomez,3 J. Cruzado.1

    1Kidney Transplantation Unit, Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; 2Nephrology Service, Hospital San Juan de Dios, San Jose, Costa Rica; 3Cardiac Intensive Care Unit, Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

    Study Purpose:Screening for silent coronary artery disease (SCAD) in patients awaiting kidney transplantation is still controversial. Indeed, guidelines of some scientific societies show important discrepancies.…
  • 2015 American Transplant Congress

    Screening for West Nile Virus in California: Resolving IgM Anti-WNV in the Area With Dengue Seroprevalence

    C. Chinchilla-Reyes,1,2 D. Tanglao,1 T. Mone,3 M. Koss,1 M. Nowicki.1,2

    1Viracor-IBT Laboratories, Los Angeles; 2Mendez National Institute of Transplantation Foundation, Los Angeles; 3OneLegacy, Los Angeles.

    West Nile Virus (WNV) symptoms develop 2-15 days after exposure with a short period of viremia (6-7 days). It is possible to detect WNV in…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences